Literature DB >> 16887383

Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease.

Livia Brusa1, Viviana Versace, Giacomo Koch, Cesare Iani, Paolo Stanzione, Giorgio Bernardi, Diego Centonze.   

Abstract

OBJECTIVE: To determine whether low-frequency repetitive transcranial magnetic stimulation (rTMS) may modulate l-DOPA-induced dyskinesia (LID) in dyskinetic Parkinson's disease (PD) patients. LID is a severe motor complication in advanced PD patients. The neural mechanisms involved in LID are not clear, and it is apparent that both an excessive decrease in internal pallidus firing and a modification and overactivation of cortical motor and premotor areas are involved in its pathogenesis.
METHODS: Using low frequency 1Hz repetitive rTMS we investigated whether decrease of excitability of the supplementary motor area (SMA) may result in modification of LID in PD patients. Furthermore we tested whether it was possible to enhance and/or prolong the beneficial effects of the treatment with repeated sessions of stimulation.
RESULTS: We observed that 1Hz rTMS induced a transient reduction of dyskinesias. A single session of rTMS improved LID, while repeated sessions of stimulation failed to enhance and/or prolong the beneficial effects of the procedure, without causing motor deterioration or other adverse effects.
CONCLUSIONS: These results suggest that LID may depend on an increased excitability of the SMA. SIGNIFICANCE: SMA rTMS is effective in reducing transiently LID, although cannot yet be considered clinically useful.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887383     DOI: 10.1016/j.clinph.2006.03.033

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  21 in total

1.  Theta burst stimulation over the primary motor cortex does not induce cortical plasticity in Parkinson's disease.

Authors:  Carsten Eggers; Gereon R Fink; Dennis A Nowak
Journal:  J Neurol       Date:  2010-05-22       Impact factor: 4.849

Review 2.  Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.

Authors:  Aparna Wagle Shukla; Jonathan J Shuster; Jae Woo Chung; David E Vaillancourt; Carolynn Patten; Jill Ostrem; Michael S Okun
Journal:  PM R       Date:  2015-08-24       Impact factor: 2.298

3.  High-frequency priming stimulation does not enhance the effect of low-frequency rTMS in the treatment of tinnitus.

Authors:  Berthold Langguth; Tobias Kleinjung; Elmar Frank; Michael Landgrebe; Philipp Sand; Jana Dvorakova; Ulrich Frick; Peter Eichhammer; Göran Hajak
Journal:  Exp Brain Res       Date:  2007-12-07       Impact factor: 1.972

4.  Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases.

Authors:  Michael D Fox; Randy L Buckner; Hesheng Liu; M Mallar Chakravarty; Andres M Lozano; Alvaro Pascual-Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

5.  Transcranial Non-Invasive Brain Stimulation in Parkinson's Disease Patients with Dyskinesias. Where is the Optimal Target?

Authors:  Antonio Cerasa; Ignacio Obeso; Michele Dileone; Aldo Quattrone
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

Review 6.  Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis.

Authors:  Ying-hui Chou; Patrick T Hickey; Mark Sundman; Allen W Song; Nan-kuei Chen
Journal:  JAMA Neurol       Date:  2015-04       Impact factor: 18.302

7.  Reversal of plasticity-like effects in the human motor cortex.

Authors:  Ying-Zu Huang; John C Rothwell; Chin-Song Lu; Wen-Li Chuang; Wey-Yil Lin; Rou-Shayn Chen
Journal:  J Physiol       Date:  2010-07-26       Impact factor: 5.182

Review 8.  Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.

Authors:  Matthew Vonloh; Robert Chen; Benzi Kluger
Journal:  Parkinsonism Relat Disord       Date:  2013-03-07       Impact factor: 4.891

Review 9.  Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

Authors:  Dhanya Vijayakumar; Joseph Jankovic
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

Review 10.  Noninvasive brain stimulation for Parkinson's disease and dystonia.

Authors:  Allan D Wu; Felipe Fregni; David K Simon; Choi Deblieck; Alvaro Pascual-Leone
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.